Skip to main content
Figure 4 | Journal of Translational Medicine

Figure 4

From: Tumor-derived TGF-β and prostaglandin E2 attenuate anti-tumor immune responses in head and neck squamous cell carcinoma treated with EGFR inhibitor

Figure 4

Responses of EGFR 875–889 -reactive CD4 + T cell clones to EGFR 875–889 peptide were attenuated by PGE2. EGFR875–889-reactive CD4+ T cell clone M8 was tested for its capacity to recognize EGFR875–889 peptide by using autologous PBMCs as APCs with or without PGE2 (1 μM) by quantification of IFN-γ production. Columns without bars had SD of <10% of mean values. Results are representative of three separate experiments. *p < 0.05.

Back to article page